Clinical Trial Update: A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Baxdrostat for reducing ambulatory blood pressure in adults with resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Baxdrostat (Baxdrostat)

Snippet

Sponsor: AstraZeneca | Conditions: Resistant Hypertension | Phase 3 | Status: COMPLETED